Healthcare provider profile · identity verified

Frank E Cibulka, M.D.

Family Practice · PHOENIX, AZ · NPI 1760472351

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	387	99
Atorvastatin Calcium	Atorvastatin Calcium	301	93
Rosuvastatin Calcium	Rosuvastatin Calcium	283	82
Metformin Hcl	Metformin Hcl	248	69
Zolpidem Tartrate	Zolpidem Tartrate	246	45
Lisinopril	Lisinopril	238	67
Amlodipine Besylate	Amlodipine Besylate	217	60
Simvastatin	Simvastatin	196	52
Tamsulosin Hcl	Tamsulosin Hcl	184	57
Clonazepam	Clonazepam	178	42
Metoprolol Succinate	Metoprolol Succinate	156	46
Gabapentin	Gabapentin	155	38
Omeprazole	Omeprazole	148	37
Pravastatin Sodium	Pravastatin Sodium	138	38
Pantoprazole Sodium	Pantoprazole Sodium	136	43
Prednisone	Prednisone	127	93
Losartan Potassium	Losartan Potassium	126	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	44
Albuterol Sulfate Hfa	Albuterol Sulfate	114	40
Alprazolam	Alprazolam	113	25
Hydrochlorothiazide	Hydrochlorothiazide	113	29
Trazodone Hcl	Trazodone Hcl	111	37
Ipratropium Bromide	Ipratropium Bromide	110	59
Trulicity	Dulaglutide	106	17
Celecoxib	Celecoxib	98	19
Furosemide	Furosemide	97	27
Potassium Chloride	Potassium Chloride	97	30
Famotidine	Famotidine	95	26
Montelukast Sodium	Montelukast Sodium	95	27
Citalopram Hbr	Citalopram Hydrobromide	94	31
Escitalopram Oxalate	Escitalopram Oxalate	92	24
Tramadol Hcl	Tramadol Hcl	91	22
Allopurinol	Allopurinol	85	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	22
Pioglitazone Hcl	Pioglitazone Hcl	82	23
Estradiol	Estradiol	77	25
Azelastine Hcl	Azelastine Hcl	75	35
Bupropion Xl	Bupropion Hcl	74	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	suppressed
Diazepam	Diazepam	65	15
Metoprolol Tartrate	Metoprolol Tartrate	65	22
Quetiapine Fumarate	Quetiapine Fumarate	61	12
Paroxetine Hcl	Paroxetine Hcl	60	13
Ozempic	Semaglutide	58	13
Eliquis	Apixaban	57	15
Oxybutynin Chloride Er	Oxybutynin Chloride	57	18
Naproxen	Naproxen	55	20
Fluoxetine Hcl	Fluoxetine Hcl	54	19
Mounjaro	Tirzepatide	53	11
Sertraline Hcl	Sertraline Hcl	52	14
Lorazepam	Lorazepam	51	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	14
Fluticasone Propionate	Fluticasone Propionate	50	16
Carvedilol	Carvedilol	49	14
Pregabalin	Pregabalin	49	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	48	14
Finasteride	Finasteride	46	12
Tresiba Flextouch U-100	Insulin Degludec	46	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	15
Metformin Hcl Er	Metformin Hcl	44	14
Oxybutynin Chloride	Oxybutynin Chloride	44	14
Hydrocortisone	Hydrocortisone	43	12
Synthroid	Levothyroxine Sodium	43	12
Fenofibrate	Fenofibrate	40	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	39	suppressed
Eszopiclone	Eszopiclone	39	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	39	13
Rybelsus	Semaglutide	39	suppressed
Azithromycin	Azithromycin	38	32
Lovastatin	Lovastatin	37	suppressed
Donepezil Hcl	Donepezil Hcl	36	14
Glimepiride	Glimepiride	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Meloxicam	Meloxicam	32	suppressed
Testosterone Cypionate	Testosterone Cypionate	32	suppressed
Mirtazapine	Mirtazapine	31	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	18
Mupirocin	Mupirocin	30	17
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	20
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Valacyclovir	Valacyclovir Hcl	26	15
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Levemir Flexpen	Insulin Detemir	25	suppressed
Linzess	Linaclotide	25	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Methylprednisolone	Methylprednisolone	23	23
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Clonidine	Clonidine	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Atenolol	Atenolol	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Calcitriol	Calcitriol	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Metronidazole	Metronidazole	15	11
Novolog Flexpen	Insulin Aspart	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Savella	Milnacipran Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Eletriptan Hbr	Eletriptan Hydrobromide	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Testosterone	Testosterone	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Metolazone	Metolazone	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Serevent Diskus	Salmeterol Xinafoate	11	suppressed
Tadalafil	Tadalafil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error